Concepedia

Publication | Open Access

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma

DOIFull Paper Access

14

Citations

16

References

2024

Year

Pallawi Torka, Tatyana Feldman, Kerry J. Savage, Nivetha Ganesan, Esther Drill, Helen Hancock, Theresa Davey, Leslie Perez, Charisse Capadona, Sarima Subzwari,
Journal of Clinical Oncology

Abstract

N-AVD is a highly effective and well-tolerated frontline regimen in OA with cHL across a wide range of geriatric impairments.

References

YearCitations

Page 1